Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Zoledronic Acid in CKD Patients on Dialysis
NCT07741136Phase 1Not yet recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of zoledronic acid in osteoporosis (3 arms), sponsored by Universidade Estadual de Campinas. Primary endpoint: Area Under the Curve of zoledronic acid at 96 hours. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07741136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07741136.